Galera Therapeutics GAAP EPS of -$0.54

Aug. 09, 2022 8:32 AM ETGalera Therapeutics, Inc. (GRTX)By: Gaurav Batavia, SA News Editor
  • Galera Therapeutics press release (NASDAQ:GRTX): Q2 GAAP EPS of -$0.54.
  • As of June 30, 2022, Galera had cash, cash equivalents and short-term investments of $52.0 million. Galera expects that its existing cash, cash equivalents and short-term investments will enable Galera to fund its operating expenses and capital expenditure requirements for at least the next twelve months.

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.